Jazz Pharmaceuticals sells women's health business
Jazz Pharmaceuticals announced that it has agreed to sell its women's health business to Swedish specialty drug maker Meda AB for $95 million in cash.
Cardinal Health has spun off its medical products division creating a nearly $4bn medical products company called CareFusion.